Healthcare -
Biotechnology - NASDAQ - US
$ 10.14
-2.12 %
$ 764 M
Market Cap
-3.34
P/E
REPL - TOTAL CURRENT LIABILITIES
Total Current Liabilities REPL - Replimune Group, Inc.
40.4 M
LAST VALUE
39.58%
2 YEAR CAGR
32.54%
5 YEAR CAGR
0.00%
10 YEAR CAGR